Literature DB >> 17616439

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.

Josephine K Swanton1, Alex Rovira, Mar Tintore, Daniel R Altmann, Frederik Barkhof, Massimo Filippi, Elena Huerga, Katherine A Miszkiel, Gordon T Plant, Chris Polman, Marco Rovaris, Alan J Thompson, Xavier Montalban, David H Miller.   

Abstract

BACKGROUND: The 2001 and 2005 McDonald criteria allow MRI evidence for dissemination in space (DIS) and dissemination in time (DIT) to be used to diagnose multiple sclerosis in patients who present with clinically isolated syndromes (CIS). In 2006, new criteria were proposed in which DIS requires at least one T2 lesion in at least two of four locations (juxtacortical, periventricular, infratentorial, and spinal-cord) and DIT requires a new T2 lesion on a follow-up scan. We applied all three criteria in a large cohort of CIS patients to assess their performance by use of conversion to clinically definite multiple sclerosis (CDMS) as the outcome.
METHODS: Patients who had two MRI scans within 12 months of CIS onset were identified in four centres in the Magnims European research network. The specificity and sensitivity of MRI criteria for CDMS after 3 years was assessed in 208 patients. A Cox proportional hazards model was applied in a larger cohort of 282 patients that included all patients irrespective of length of follow-up.
FINDINGS: The specificity of all criteria for CDMS was high (2001 McDonald, 91%; 2005 McDonald, 88%; new, 87%). Sensitivity of the new (72%) and 2005 McDonald (60%) criteria were higher than the 2001 McDonald criteria (47%). The Cox proportional hazards model showed a higher conversion risk for all three criteria in those with both DIS and DIT than those with either DIS or DIT alone. When all three criteria were included in the model, only the new criteria had an independent significant effect on conversion risk.
INTERPRETATION: The new criteria are simpler than the McDonald criteria without compromising specificity and accuracy. The presence of both DIS and DIT from two MRI scans has a higher specificity and risk for CDMS than either DIS or DIT alone.

Entities:  

Mesh:

Year:  2007        PMID: 17616439     DOI: 10.1016/S1474-4422(07)70176-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  71 in total

1.  Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome.

Authors:  D T Okuda; E M Mowry; B A C Cree; E C Crabtree; D S Goodin; E Waubant; D Pelletier
Journal:  Neurology       Date:  2011-01-26       Impact factor: 9.910

2.  From injection therapies to natalizumab: views on the treatment of multiple sclerosis.

Authors:  Roberto Bomprezzi; Darin T Okuda; Yazan J Alderazi; Olaf Stüve; Elliot M Frohman
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

Review 3.  Contribution of magnetic resonance imaging to the diagnosis and monitoring of multiple sclerosis.

Authors:  M A Rocca; N Anzalone; A Falini; M Filippi
Journal:  Radiol Med       Date:  2012-03-19       Impact factor: 3.469

Review 4.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

5.  Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Authors:  Angeliki Filippatou; Thomas Shoemaker; Megan Esch; Madiha Qutab; Natalia Gonzalez-Caldito; Jerry L Prince; Ellen M Mowry; Peter A Calabresi; Shiv Saidha; Elias S Sotirchos
Journal:  Mult Scler       Date:  2018-12-03       Impact factor: 6.312

Review 6.  [Clinically isolated syndrome].

Authors:  M Platten; T Lanz; M Bendszus; R Diem
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

7.  Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Authors:  B Mark Keegan; Timothy J Kaufmann; Brian G Weinshenker; Orhun H Kantarci; William F Schmalstieg; M Mateo Paz Soldan; Eoin P Flanagan
Journal:  Neurology       Date:  2016-09-16       Impact factor: 9.910

Review 8.  MR imaging in multiple sclerosis: review and recommendations for current practice.

Authors:  K-O Lövblad; N Anzalone; A Dörfler; M Essig; B Hurwitz; L Kappos; S-K Lee; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

Review 9.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

10.  IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.

Authors:  Magdalena Huber; Sylvia Heink; Axel Pagenstecher; Katharina Reinhard; Josephine Ritter; Alexander Visekruna; Anna Guralnik; Nadine Bollig; Katharina Jeltsch; Christina Heinemann; Eva Wittmann; Thorsten Buch; Olivia Prazeres da Costa; Anne Brüstle; Dirk Brenner; Tak W Mak; Hans-Willi Mittrücker; Björn Tackenberg; Thomas Kamradt; Michael Lohoff
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.